What is ChatGPT? ChatGPT (Chat Generative Pre-trained Transformer) is a large language model (LLM)-based artificial intelligence (AI) released by OpenAI...
Top 5 Challenges of Running Esophageal Cancer Clinical Trials
With over 550,000 new cases diagnosed each year, esophageal cancer is the seventh most common type of cancer worldwide. The...
San Francisco’s Top 6 CROs Specializing in Rare Disease Clinical Trials
Rare diseases are conditions with a low prevalence which can be severe, life-threatening, and disabling. Due to an inconsistency in...
The Rise of Biotech Podcasts: The New Frontier of Knowledge Discovery
Podcasts have come a long way from their humble beginnings in the 2000s. There are millions of series hosted on...
The Role of GPT-4 in Drug Discovery
GPT-4 is a generative AI model that responds to text and images. You’re probably familiar with ChatGPT, which is a...
CROs and the Regulatory Landscape: How to Ensure Clinical Trial Compliance
Although it may be surprising to consider, today’s stringent governing oversight of clinical trial activities is, in fact, a relatively...
Picking a Phase I Site: Key Questions for Startup Biotech Teams to Ask
Clinical trials are essential in testing the safety and effectiveness of new drugs and medical devices. The success of these...
The Current Landscape of IBS Clinical Trials in 2023
Irritable bowel syndrome (IBS) is a highly prevalent, functional gastrointestinal condition that is both costly and debilitating. Between 9% and...
Has AlphaFold Changed Drug Discovery?
Despite the simplicity of its name, drug discovery broadly encompasses the rigorous process of identifying chemical compounds, also known as...
